Trial Profile
Comparison between Lusutrombopag and effectiveness of the platelet blood transfusion
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2020
Price :
$35
*
At a glance
- Drugs Lusutrombopag (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 01 Sep 2020 Primary endpoint has been met. (Platelet growth rate)
- 01 Sep 2020 Results assessing efficacy and proportion of responders of lusutrombopag compared with platelet transfusion for chronic liver disease with thrombocytopenia, published in the Hepatology Research
- 14 Jun 2018 New trial record